MIRUMIR

MIRUMIR evaluates the prognostic value of microRNAs (miRNAs) for predicting survival outcomes in cancer patients by integrating multiple clinical datasets.

Key Features:

• Comprehensive Analysis: Integrates data from diverse clinical studies to assess miRNA expression and its association with patient survival.
• Statistical Rigor: Applies statistical methods to analyze the correlation between miRNA expression levels and patient survival rates.
• Cross-Cancer Applicability: Utilizes datasets from multiple cancer types to identify miRNAs with pan-cancer or cancer-specific prognostic associations.

Scientific Applications:

• Research and Development: Identification of candidate miRNA biomarkers for experimental validation in cancer biology studies.
• Clinical Decision-Making: Generates prognostic insights that can inform clinical research and exploratory patient stratification by oncologists.
• Biomarker Discovery: Aids discovery of novel miRNAs as diagnostic or prognostic biomarkers by linking miRNA expression to survival outcomes.

Methodology:

Integrates multiple clinical miRNA expression datasets and applies statistical analyses correlating miRNA expression with patient survival.